Fazekas T, Vos M A, Leunissen J D, Wellens H J
Department of Cardiology, University of Limburg, Maastricht, The Netherlands.
Acta Physiol Hung. 1993;81(1):59-70.
A study was made of whether the administration of magnesium or ethmozin to conscious dogs with normal plasma Mg levels (0.75 +/- 0.06 mmol/l) terminates ouabain-induced ventricular tachycardia, an arrhythmia which is dependent on triggered activity resulting from delayed afterdepolarizations. Sustained monomorphic ventricular tachycardia was induced by programmed ventricular pacing during the continuous iv. infusion of ouabain to animals with a formaldehyde-induced permanent complete AV block. A single dose of MgSO4 (100 mg/kg b.w. iv.) abolished only those ventricular tachycardias with cycle lengths > 325 ms (inverse use-dependency); ventricular tachycardias with cycle lengths < 320 ms were merely slowed, despite the fact that the increase in plasma Mg levels was considerable and comparable in both groups (3.9 +/- 1.6 and 4.8 +/- 1.9 mmol/l). In contrast, ethmozin (2 mg/kg b.w. iv.) terminated both fast and slow ventricular tachycardias. It is concluded that ethmozin (moricizine) is more effective than the traditionally used MgSO4 in terminating ventricular tachycardia resulting from cardiac glycoside toxicity.
对血浆镁水平正常(0.75±0.06 mmol/l)的清醒犬给予镁或乙吗噻嗪,观察其是否能终止哇巴因诱发的室性心动过速,这种心律失常依赖于延迟后除极所导致的触发活动。在给甲醛诱导的永久性完全性房室传导阻滞动物持续静脉输注哇巴因期间,通过程控心室起搏诱发持续性单形性室性心动过速。单次静脉注射硫酸镁(100 mg/kg体重)仅能消除那些周期长度>325 ms的室性心动过速(反向频率依赖性);尽管两组血浆镁水平升高幅度相当且可观(分别为3.9±1.6和4.8±1.9 mmol/l),但周期长度<320 ms的室性心动过速仅被减慢。相比之下,乙吗噻嗪(2 mg/kg体重静脉注射)能终止快速和慢速室性心动过速。得出的结论是,在终止由强心苷毒性导致的室性心动过速方面,乙吗噻嗪(莫雷西嗪)比传统使用的硫酸镁更有效。